检索结果 - Busque, Stephan
- Showing 1 - 20 results of 21
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
Tolerance and Withdrawal of Immunosuppressive Drugs in Patients Given Kidney and Hematopoietic Cell Transplants 由 Scandling, John D., Busque, Stephan, Dejbakhsh-Jones, Sussan, Benike, Claudia, Sarwal, Minnie, Millan, Maria T., Shizuru, Judith A., Lowsky, Robert, Engleman, Edgar G., Strober., Samuel
出版 2012Text -
16
Trends in Cost Attributable to Kidney Transplantation Evaluation and Waiting List Management in the United States, 2012-2017 由 Cheng, Xingxing S., Han, Jialin, Braggs-Gresham, Jennifer L., Held, Philip J., Busque, Stephan, Roberts, John P., Tan, Jane C., Scandling, John D., Chertow, Glenn M., Dor, Avi
出版 2022Text -
17
Efficacy and Safety of a Tofacitinib-based Immunosuppressive Regimen After Kidney Transplantation: Results From a Long-term Extension Trial 由 Busque, Stephan, Vincenti, Flavio G., Tedesco Silva, Helio, O’Connell, Philip J., Yoshida, Atsushi, Friedewald, John J., Steinberg, Steven M., Budde, Klemens, Broeders, Emine N., Kim, Yon Su, Hahn, Carolyn M., Li, Huihua, Chan, Gary
出版 2018Text -
18
Cellular and humoral immune response to SARS-CoV-2 vaccination and booster dose in immunosuppressed patients: An observational cohort study 由 Yang, Lu M., Costales, Cristina, Ramanathan, Muthukumar, Bulterys, Philip L., Murugesan, Kanagavel, Schroers-Martin, Joseph, Alizadeh, Ash A., Boyd, Scott D., Brown, Janice M., Nadeau, Kari C., Nadimpalli, Sruti S., Wang, Aileen X., Busque, Stephan, Pinsky, Benjamin A., Banaei, Niaz
出版 2022Text -
19
Mixed chimerism and acceptance of kidney transplants after immunosuppressive drug withdrawal 由 Busque, Stephan, Scandling, John D., Lowsky, Robert, Shizuru, Judith, Jensen, Kent, Waters, Jeffrey, Wu, Hsin-Hsu, Sheehan, Kevin, Shori, Asha, Choi, Okmi, Pham, Thomas, Fernandez Vina, Marcelo A., Hoppe, Richard, Tamaresis, John, Lavori, Philip, Engleman, Edgar G., Meyer, Everett, Strober, Samuel
出版 2020Text -
20
Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti‐CD20 monoclonal antibody for the desensitization of candidates for renal transplant 由 Redfield, Robert R., Jordan, Stanley C., Busque, Stephan, Vincenti, Flavio, Woodle, E. Steve, Desai, Niraj, Reed, Elaine F., Tremblay, Simon, Zachary, Andrea A., Vo, Ashley A., Formica, Richard, Schindler, Thomas, Tran, Ha, Looney, Caroline, Jamois, Candice, Green, Cherie, Morimoto, Alyssa, Rajwanshi, Richa, Schroeder, Aaron, Cascino, Matthew D., Brunetta, Paul, Borie, Dominic
出版 2019Text